Global Microfluidic Equipment Market Overview

Microfluidic Equipment Market size is projected to reach xxxx units by 2025 from an estimated xxxx unit in 2019, growing at a CAGR of xx% globally.

Introspective Market Research provides the newest industry data about Microfluidic Equipment Market and industry future trends, allowing you to identify the products and end users driving revenue growth and profitability. The Microfluidic Equipment industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.

Scope of the Microfluidic Equipment Market

The main goal of this report is to help users understand the Microfluidic Equipment market in terms of its definition, segmentation, market potential, influential trends, and challenges facing the market. In-depth research and analysis took place while preparing the report. Readers will find this report very helpful to in-depth understanding of the market.

Market Segmentation



Players Covered in Microfluidic Equipment market are :

  • Abbott Laboratories
  • Agilent Technologies
  • BD
  • Bio-Rad Laboratories
  • Cepheid
  • Dolomite
  • Roche
  • Fluidigm Corporation
  • Johnson & Johnson
  • Micronit Microfluidics
  • RainDance Technologies
  • Siemens Healthcare

Microfluidic Equipment Market - Global Demand & Analysis
Segmentations by Type
  • Glass
  • Polymer
  • Silicon
by Application
  • In-vitro Diagnostics (IVD)
  • Pharmaceuticals
  • Medical Devices
by Region
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Southeast Asia, Rest of APAC)
  • Middle East & Africa (GCC Countries, South Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of South America)
Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Application

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  3.5.1 Drivers
  3.5.2 Restraints
  3.5.3 Opportunities
  3.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 4: Microfluidic Equipment Market by Type
 4.1 Microfluidic Equipment Market Overview Snapshot and Growth Engine
 4.2 Microfluidic Equipment Market Overview
 4.3 Glass
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size (2016-2028F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Glass: Grographic Segmentation
 4.4 Polymer
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size (2016-2028F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Polymer: Grographic Segmentation
 4.5 Silicon
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size (2016-2028F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Silicon: Grographic Segmentation

Chapter 5: Microfluidic Equipment Market by Application
 5.1 Microfluidic Equipment Market Overview Snapshot and Growth Engine
 5.2 Microfluidic Equipment Market Overview
 5.3 In-vitro Diagnostics (IVD)
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 In-vitro Diagnostics (IVD): Grographic Segmentation
 5.4 Pharmaceuticals
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Pharmaceuticals: Grographic Segmentation
 5.5 Medical Devices
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Medical Devices: Grographic Segmentation

Chapter 6: Company Profiles and Competitive Analysis
 6.1 Competitive Landscape
  6.1.1 Competitive Positioning
  6.1.2 Microfluidic Equipment Sales and Market Share By Players
  6.1.3 Industry BCG Matrix
  6.1.4 Ansoff Matrix
  6.1.5 Microfluidic Equipment Industry Concentration Ratio (CR5 and HHI)
  6.1.6 Top 5 Microfluidic Equipment Players Market Share
  6.1.7 Mergers and Acquisitions
  6.1.8 Business Strategies By Top Players
 6.2 ABBOTT LABORATORIES
  6.2.1 Company Overview
  6.2.2 Key Executives
  6.2.3 Company Snapshot
  6.2.4 Operating Business Segments
  6.2.5 Product Portfolio
  6.2.6 Business Performance
  6.2.7 Key Strategic Moves and Recent Developments
  6.2.8 SWOT Analysis
 6.3 AGILENT TECHNOLOGIES
 6.4 BD
 6.5 BIO-RAD LABORATORIES
 6.6 CEPHEID
 6.7 DOLOMITE
 6.8 ROCHE
 6.9 FLUIDIGM CORPORATION
 6.10 JOHNSON & JOHNSON
 6.11 MICRONIT MICROFLUIDICS
 6.12 RAINDANCE TECHNOLOGIES
 6.13 SIEMENS HEALTHCARE

Chapter 7: Global Microfluidic Equipment Market Analysis, Insights and Forecast, 2016-2028
 7.1 Market Overview
 7.2 Historic and Forecasted Market Size By Type
  7.2.1 Glass
  7.2.2 Polymer
  7.2.3 Silicon
 7.3 Historic and Forecasted Market Size By Application
  7.3.1 In-vitro Diagnostics (IVD)
  7.3.2 Pharmaceuticals
  7.3.3 Medical Devices

Chapter 8: North America Microfluidic Equipment Market Analysis, Insights and Forecast, 2016-2028
 8.1 Key Market Trends, Growth Factors and Opportunities
 8.2 Impact of Covid-19
 8.3 Key Players
 8.4 Key Market Trends, Growth Factors and Opportunities
 8.4 Historic and Forecasted Market Size By Type
  8.4.1 Glass
  8.4.2 Polymer
  8.4.3 Silicon
 8.5 Historic and Forecasted Market Size By Application
  8.5.1 In-vitro Diagnostics (IVD)
  8.5.2 Pharmaceuticals
  8.5.3 Medical Devices
 8.6 Historic and Forecast Market Size by Country
  8.6.1 U.S.
  8.6.2 Canada
  8.6.3 Mexico

Chapter 9: Europe Microfluidic Equipment Market Analysis, Insights and Forecast, 2016-2028
 9.1 Key Market Trends, Growth Factors and Opportunities
 9.2 Impact of Covid-19
 9.3 Key Players
 9.4 Key Market Trends, Growth Factors and Opportunities
 9.4 Historic and Forecasted Market Size By Type
  9.4.1 Glass
  9.4.2 Polymer
  9.4.3 Silicon
 9.5 Historic and Forecasted Market Size By Application
  9.5.1 In-vitro Diagnostics (IVD)
  9.5.2 Pharmaceuticals
  9.5.3 Medical Devices
 9.6 Historic and Forecast Market Size by Country
  9.6.1 Germany
  9.6.2 U.K.
  9.6.3 France
  9.6.4 Italy
  9.6.5 Russia
  9.6.6 Spain

Chapter 10: Asia-Pacific Microfluidic Equipment Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 Glass
  10.4.2 Polymer
  10.4.3 Silicon
 10.5 Historic and Forecasted Market Size By Application
  10.5.1 In-vitro Diagnostics (IVD)
  10.5.2 Pharmaceuticals
  10.5.3 Medical Devices
 10.6 Historic and Forecast Market Size by Country
  10.6.1 China
  10.6.2 India
  10.6.3 Japan
  10.6.4 Southeast Asia

Chapter 11: South America Microfluidic Equipment Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Glass
  11.4.2 Polymer
  11.4.3 Silicon
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 In-vitro Diagnostics (IVD)
  11.5.2 Pharmaceuticals
  11.5.3 Medical Devices
 11.6 Historic and Forecast Market Size by Country
  11.6.1 Brazil
  11.6.2 Argentina

Chapter 12: Middle East & Africa Microfluidic Equipment Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Glass
  12.4.2 Polymer
  12.4.3 Silicon
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 In-vitro Diagnostics (IVD)
  12.5.2 Pharmaceuticals
  12.5.3 Medical Devices
 12.6 Historic and Forecast Market Size by Country
  12.6.1 Saudi Arabia
  12.6.2 South Africa

Chapter 13 Investment Analysis

Chapter 14 Analyst Viewpoint and Conclusion
Microfluidic Equipment Market - Global Demand & Analysis
Segmentations by Type
  • Glass
  • Polymer
  • Silicon
by Application
  • In-vitro Diagnostics (IVD)
  • Pharmaceuticals
  • Medical Devices
by Region
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Southeast Asia, Rest of APAC)
  • Middle East & Africa (GCC Countries, South Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of South America)
LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. MICROFLUIDIC EQUIPMENT MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. MICROFLUIDIC EQUIPMENT MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. MICROFLUIDIC EQUIPMENT MARKET COMPETITIVE RIVALRY
TABLE 005. MICROFLUIDIC EQUIPMENT MARKET THREAT OF NEW ENTRANTS
TABLE 006. MICROFLUIDIC EQUIPMENT MARKET THREAT OF SUBSTITUTES
TABLE 007. MICROFLUIDIC EQUIPMENT MARKET BY TYPE
TABLE 008. GLASS MARKET OVERVIEW (2016-2028)
TABLE 009. POLYMER MARKET OVERVIEW (2016-2028)
TABLE 010. SILICON MARKET OVERVIEW (2016-2028)
TABLE 011. MICROFLUIDIC EQUIPMENT MARKET BY APPLICATION
TABLE 012. IN-VITRO DIAGNOSTICS (IVD) MARKET OVERVIEW (2016-2028)
TABLE 013. PHARMACEUTICALS MARKET OVERVIEW (2016-2028)
TABLE 014. MEDICAL DEVICES MARKET OVERVIEW (2016-2028)
TABLE 015. NORTH AMERICA MICROFLUIDIC EQUIPMENT MARKET, BY TYPE (2016-2028)
TABLE 016. NORTH AMERICA MICROFLUIDIC EQUIPMENT MARKET, BY APPLICATION (2016-2028)
TABLE 017. N MICROFLUIDIC EQUIPMENT MARKET, BY COUNTRY (2016-2028)
TABLE 018. EUROPE MICROFLUIDIC EQUIPMENT MARKET, BY TYPE (2016-2028)
TABLE 019. EUROPE MICROFLUIDIC EQUIPMENT MARKET, BY APPLICATION (2016-2028)
TABLE 020. MICROFLUIDIC EQUIPMENT MARKET, BY COUNTRY (2016-2028)
TABLE 021. ASIA PACIFIC MICROFLUIDIC EQUIPMENT MARKET, BY TYPE (2016-2028)
TABLE 022. ASIA PACIFIC MICROFLUIDIC EQUIPMENT MARKET, BY APPLICATION (2016-2028)
TABLE 023. MICROFLUIDIC EQUIPMENT MARKET, BY COUNTRY (2016-2028)
TABLE 024. MIDDLE EAST & AFRICA MICROFLUIDIC EQUIPMENT MARKET, BY TYPE (2016-2028)
TABLE 025. MIDDLE EAST & AFRICA MICROFLUIDIC EQUIPMENT MARKET, BY APPLICATION (2016-2028)
TABLE 026. MICROFLUIDIC EQUIPMENT MARKET, BY COUNTRY (2016-2028)
TABLE 027. SOUTH AMERICA MICROFLUIDIC EQUIPMENT MARKET, BY TYPE (2016-2028)
TABLE 028. SOUTH AMERICA MICROFLUIDIC EQUIPMENT MARKET, BY APPLICATION (2016-2028)
TABLE 029. MICROFLUIDIC EQUIPMENT MARKET, BY COUNTRY (2016-2028)
TABLE 030. ABBOTT LABORATORIES: SNAPSHOT
TABLE 031. ABBOTT LABORATORIES: BUSINESS PERFORMANCE
TABLE 032. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 033. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 033. AGILENT TECHNOLOGIES: SNAPSHOT
TABLE 034. AGILENT TECHNOLOGIES: BUSINESS PERFORMANCE
TABLE 035. AGILENT TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 036. AGILENT TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 036. BD: SNAPSHOT
TABLE 037. BD: BUSINESS PERFORMANCE
TABLE 038. BD: PRODUCT PORTFOLIO
TABLE 039. BD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 039. BIO-RAD LABORATORIES: SNAPSHOT
TABLE 040. BIO-RAD LABORATORIES: BUSINESS PERFORMANCE
TABLE 041. BIO-RAD LABORATORIES: PRODUCT PORTFOLIO
TABLE 042. BIO-RAD LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 042. CEPHEID: SNAPSHOT
TABLE 043. CEPHEID: BUSINESS PERFORMANCE
TABLE 044. CEPHEID: PRODUCT PORTFOLIO
TABLE 045. CEPHEID: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. DOLOMITE: SNAPSHOT
TABLE 046. DOLOMITE: BUSINESS PERFORMANCE
TABLE 047. DOLOMITE: PRODUCT PORTFOLIO
TABLE 048. DOLOMITE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. ROCHE: SNAPSHOT
TABLE 049. ROCHE: BUSINESS PERFORMANCE
TABLE 050. ROCHE: PRODUCT PORTFOLIO
TABLE 051. ROCHE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. FLUIDIGM CORPORATION: SNAPSHOT
TABLE 052. FLUIDIGM CORPORATION: BUSINESS PERFORMANCE
TABLE 053. FLUIDIGM CORPORATION: PRODUCT PORTFOLIO
TABLE 054. FLUIDIGM CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. JOHNSON & JOHNSON: SNAPSHOT
TABLE 055. JOHNSON & JOHNSON: BUSINESS PERFORMANCE
TABLE 056. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 057. JOHNSON & JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. MICRONIT MICROFLUIDICS: SNAPSHOT
TABLE 058. MICRONIT MICROFLUIDICS: BUSINESS PERFORMANCE
TABLE 059. MICRONIT MICROFLUIDICS: PRODUCT PORTFOLIO
TABLE 060. MICRONIT MICROFLUIDICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. RAINDANCE TECHNOLOGIES: SNAPSHOT
TABLE 061. RAINDANCE TECHNOLOGIES: BUSINESS PERFORMANCE
TABLE 062. RAINDANCE TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 063. RAINDANCE TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 063. SIEMENS HEALTHCARE: SNAPSHOT
TABLE 064. SIEMENS HEALTHCARE: BUSINESS PERFORMANCE
TABLE 065. SIEMENS HEALTHCARE: PRODUCT PORTFOLIO
TABLE 066. SIEMENS HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. MICROFLUIDIC EQUIPMENT MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. MICROFLUIDIC EQUIPMENT MARKET OVERVIEW BY TYPE
FIGURE 012. GLASS MARKET OVERVIEW (2016-2028)
FIGURE 013. POLYMER MARKET OVERVIEW (2016-2028)
FIGURE 014. SILICON MARKET OVERVIEW (2016-2028)
FIGURE 015. MICROFLUIDIC EQUIPMENT MARKET OVERVIEW BY APPLICATION
FIGURE 016. IN-VITRO DIAGNOSTICS (IVD) MARKET OVERVIEW (2016-2028)
FIGURE 017. PHARMACEUTICALS MARKET OVERVIEW (2016-2028)
FIGURE 018. MEDICAL DEVICES MARKET OVERVIEW (2016-2028)
FIGURE 019. NORTH AMERICA MICROFLUIDIC EQUIPMENT MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. EUROPE MICROFLUIDIC EQUIPMENT MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. ASIA PACIFIC MICROFLUIDIC EQUIPMENT MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. MIDDLE EAST & AFRICA MICROFLUIDIC EQUIPMENT MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. SOUTH AMERICA MICROFLUIDIC EQUIPMENT MARKET OVERVIEW BY COUNTRY (2016-2028)
Please Wait...

Frequently Asked Questions :

What would be forecast period in the market research report?
The forecast period in the market research report is 2021-2025.
Who are the key players in Microfluidic Equipment market?
The key players mentioned are Abbott Laboratories, Agilent Technologies, BD, Bio-Rad Laboratories, Cepheid, Dolomite, Roche, Fluidigm Corporation, Johnson & Johnson, Micronit Microfluidics, RainDance Technologies, Siemens Healthcare.
What are the segments of Microfluidic Equipment market?
The Microfluidic Equipment market is segmented into application type, product type and region. By Application type, the market is categorized into In-vitro Diagnostics (IVD), Pharmaceuticals, Medical Devices. By product type, it is classified into Glass, Polymer, Silicon and others. By region, it is analysed across North America (U.S.; Canada; Mexico), Europe (Germany; U.K.; France; Italy; Russia; Spain etc.), Asia-Pacific (China; India; Japan; Southeast Asia etc.), South America (Brazil; Argentina etc.), Middle East & Africa (Saudi Arabia; South Africa etc.).
What is the Microfluidic Equipment market?
Microfluidic Equipment Market size is projected to reach xxxx units by 2025 from an estimated xxxx unit in 2020, growing at a CAGR of xx% globally.
How big is the Microfluidic Equipment market?
The global Microfluidic Equipment market size was estimated at USD XX billion in 2020 and is expected to reach USD XX billion in 2025.